Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
H.C. Wainwright Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $12
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)
Emergent BioSolutions Earnings Call Highlights Turnaround Momentum
Emergent BioSolutions | 10-Q: Q1 2026 Earnings Report
Earnings Call Summary | Emergent BioSolutions(EBS.US) Q1 2026 Earnings Conference
Emergent BioSolutions Posts Weak Q1 Results Amid Turnaround